Vise Technologies Inc. Makes New Investment in Humana Inc. $HUM

Vise Technologies Inc. bought a new stake in shares of Humana Inc. (NYSE:HUM) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 2,463 shares of the insurance provider’s stock, valued at approximately $978,000.

Other large investors also recently made changes to their positions in the company. Wilkerson Advisory Group LLC raised its holdings in shares of Humana by 24.6% during the second quarter. Wilkerson Advisory Group LLC now owns 167 shares of the insurance provider’s stock worth $66,000 after acquiring an additional 33 shares in the last quarter. Bogart Wealth LLC raised its stake in shares of Humana by 192.0% during the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock worth $29,000 after purchasing an additional 48 shares in the last quarter. Fiduciary Alliance LLC lifted its holdings in shares of Humana by 0.9% during the 1st quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider’s stock valued at $976,000 after buying an additional 49 shares during the last quarter. Sanctuary Advisors LLC lifted its holdings in shares of Humana by 1.6% during the 4th quarter. Sanctuary Advisors LLC now owns 3,389 shares of the insurance provider’s stock valued at $868,000 after buying an additional 52 shares during the last quarter. Finally, Horizon Investments LLC grew its stake in shares of Humana by 2.5% in the 4th quarter. Horizon Investments LLC now owns 2,236 shares of the insurance provider’s stock valued at $573,000 after buying an additional 55 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of research reports. Oppenheimer restated an “outperform” rating and issued a $405.00 price objective on shares of Humana in a report on Thursday, July 30th. Zacks Research cut shares of Humana from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 11th. William Blair started coverage on shares of Humana in a research report on Wednesday, May 20th. They issued an “outperform” rating for the company. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Humana in a report on Thursday, July 30th. They set a “hold” rating on the stock. Finally, Wolfe Research upgraded shares of Humana from a “peer perform” rating to an “outperform” rating in a report on Thursday, July 30th. Fourteen analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $395.22.

Humana Price Performance

NYSE HUM opened at $379.22 on Friday. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $428.88. The company has a fifty day simple moving average of $383.38 and a 200 day simple moving average of $281.59. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. The company has a market cap of $45.54 billion, a P/E ratio of 35.88, a P/E/G ratio of 2.17 and a beta of 0.72.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping the consensus estimate of $7.27 by $0.34. The firm had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business’s quarterly revenue was up 26.2% on a year-over-year basis. During the same quarter last year, the firm posted $6.27 EPS. On average, sell-side analysts predict that Humana Inc. will post 9.08 EPS for the current year.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.